Breaking News Instant updates and real-time market news.

NXPI

NXP Semiconductors

$102.01

5.89 (6.13%)

, QCOM

Qualcomm

$68.50

1.05 (1.56%)

19:06
10/02/16
10/02
19:06
10/02/16
19:06

NXP hires investment bank amid Qualcomm interest, Bloomberg says

NXP Semiconductors (NXPI) retained Qatalyst Partners amid interest from Qualcomm (QCOM), Bloomberg reported Friday, citing sources. The investment bank will start a formal sales process to find a buyer for NXP, the sources told Bloomberg. Aside from Qualcomm, Avago, Intel (INTC) and Samsung (SSNLF) are most likely to be interested, one of the sources said. Reference Link

NXPI

NXP Semiconductors

$102.01

5.89 (6.13%)

QCOM

Qualcomm

$68.50

1.05 (1.56%)

INTC

Intel

$37.75

0.43 (1.15%)

SSNLF

Samsung

  • 23

    Oct

NXPI NXP Semiconductors
$102.01

5.89 (6.13%)

09/30/16
RHCO
09/30/16
NO CHANGE
RHCO
NXP Semiconductors could be acquired for $124 per share, says SunTrust
After Dow Jones reported that NXP (NXPI) is in talks to be bought by Qualcomm (QCOM) for more than $95 per share, SunTrust analyst William Stein says that, based on recent takeover valuations in the semiconductor space, NXP would be acquired for $124 per share. The analyst says that NXP is worth $104 per share on a standalone basis, and he does not expect the company to sell itself for $95. Stein adds that NXP would improve Qualcomm's efforts in NFC and automotive. He expects NXP's stock to rise whether or not a deal is made, and he keeps a Buy rating on the shares.
09/30/16
MZHO
09/30/16
UPGRADE
MZHO
Buy
Qualcomm upgraded on potential NXP Semiconductors acquisition at Mizuho
As previously reported, Mizuho upgraded Qualcomm (QCOM) to Buy from Neutral. The firm's analyst believes a Qualcomm (QCOM) acquisition of NXP Semiconductors (NXPI) makes significant strategic and financial sense. Qualcomm dominates automotive telematics and the firm believes the potential acquisition of NXP Semiconductors will give it incockpit market share, powertrain, safety, and an automotive processor portfolio from Freescale that creates the first end-to-end semiconductor auto supplier of the future.
09/30/16
09/30/16
DOWNGRADE

NXP Semiconductors downgraded to Add from Buy at AlphaValue
AlphaValue analyst Charles Bordes downgraded NXP Semiconductors to Add buy raised his price target for the shares to $104 from $103.
09/30/16
OPCO
09/30/16
NO CHANGE
OPCO
NXP 'cheap' for Qualcomm even after rally, says Oppenheimer
Oppenheimer analyst Rick Schafer says NXP Semiconductors (NXPI) still a "cheap" takeover target for Qualcomm (QCOM) even after rallying 25% over the past two days. An acquisition would be accretive to Qualcomm's earnings "under most scenarios," the analyst tells investors in an intraday research note. He thinks Qualcomm needs to diversify away from handsets and has $31B of offshore cash, the analyst contends. Schafer keeps a Perform rating on Qualcomm.
QCOM Qualcomm
$68.50

1.05 (1.56%)

09/30/16
09/30/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded on potential NXP Semiconductors acquisition at Mizuho with the firm's analyst saying he believes a Qualcomm acquisition of NXP Semiconductors (NXPI) makes significant strategic and financial sense. 2. Skechers (SKX) upgraded to Positive from Neutral at Susquehanna. 3. Sprouts Farmers Markets (SFM) upgraded to Buy from Hold at Jefferies with analyst Christopher Mandeville saying the risk/reward is now favorable following the recent pullback in the shares. 4. Phillips 66 (PSX) upgraded to Neutral from Sell at Goldman with analyst Neil Mehta citing higher multiple assumptions for midstream and chemicals segments, reduced capex spending and higher free cash flow estimates, and more achievable consensus expectations. 5. NetApp (NTAP) upgraded to Buy from Sell at Summit Redstone with analyst Srini Nandury citing optimism that the company can grow its product revenue from current levels driven by AFA sales and increasing adoption of clustered ONTAP. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
INTC Intel
$37.75

0.43 (1.15%)

09/20/16
09/20/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ford (F) initiated with a Buy at Nomura. 2. Intel (INTC) was initiated with a Positive at Susquehanna while the firm initiated AMD (AMD) with a Neutral. 3. HSN, Inc. (HSNI) initiated with an Underperform at BofA/Merrill. 4. Bojangles (BOJA) initiated with a Strong Buy at CL King. 5. D.R. Horton (DHI) initiated with an Outperform at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/16
BMUR
09/20/16
NO CHANGE
Target $40
BMUR
Buy
Intel guidance raise not a surprise, says Brean Capital
Brean Capital analyst Mike Burton noted Intel raised its guidance last week citing the replenishment of the PC supply chain inventory and improving PC demand. The analyst said he was not surprised by the announcement given anecdotal positive data from many of the suppliers in the sector. Burton believes Intel remains well positioned and so reiterated his Buy rating and increased his price target to $40 from $38 on Intel shares.
09/20/16
SUSQ
09/20/16
INITIATION
Target $42
SUSQ
Positive
Intel initiated with a Positive at Susquehanna
Susquehanna analyst Christopher Rolland initiated Intel with a Positive and a $42 price target saying the company has the ability to extract value through process leadership and the best wafer manufacturing in the world.
09/20/16
ADAM
09/20/16
NO CHANGE
Target $44
ADAM
Buy
Intel price target raised to $44 from $40 at Canaccord
Canaccord analyst Matthew Ramsay raised his price target on Intel to $44 from $40 following the company's positive pre-announcement. The analyst increased his estimates as well and said with its attractive dividend yield and valuation, Intel should be a core holding for investors. Ramsay reiterated his Buy rating on Intel shares.
SSNLF Samsung

04/13/16
ROTH
04/13/16
NO CHANGE
Target $2.6
ROTH
Buy
Digital Turbine estimates, price target reduced at Roth Capital
Roth Capital analyst Brian Alger reduced his estimates for Digital Turbine (APPS) and lowered his price target on the shares to $2.60 from $3, after the company quantified the miss that it had previewed last month. The shortfall was attributed to the slashed digital ad budget of a large advertising customer, Verizon (VZ) choosing to reduce the number of slots per device for much of the March quarter, and to Verizon Samsung S7's (SSNLF) that have yet to have Ignite software included, the analyst tells investors in a research note. Alger reiterates a Buy rating on Digital Turbine's shares, considering the depressed current valuation.
04/26/16
NEED
04/26/16
NO CHANGE
NEED
Apple supply chain names to rebound, says Needham
Needham analyst Rajvindra Gill expects a rebound in the Apple (AAPL) supply chain names given its underperformance over the last 25 days and the relatively good quarterly results from Knowles (KN). Among the names, the analyst sees Cirrus Logic (CRUS) increasing its dollar content per unit about 40% for the iPhone 7 cycle, with possible upside of 80%-100% for the iPhone 7S in 2017 with the inclusion of adaptive noise cancellation. Knowles, which generated 25% of sales from Apple and less than 10% of sales from Samsung (SSNLF), posted better-than-expected results and guidance, the analyst tells investors in a research note.
06/23/16
BFIN
06/23/16
NO CHANGE
BFIN
Fitbit faces 'fight of its life,' GoPro Karma delay a problem, says BlueFin
In an update on the wearable space, BlueFin analysts John Donovan and Steve Mullane make the case that Fitbit (FIT) is "in for the fight of its life" given mounting competition that is coming from Samsung (SSNLF), Apple (AAPL), Garmin (GRMN) and Under Armour (UA), adding that the sizable inventory of Alta and Blaze devices that it must deplete in this competitive environment puts Fitbit is in a "precarious position." The analyst add that Apple's watchOS improvements "further paint Fitbit into a corner," but noted that market data suggests consumers are looking for wearables under $200, which is in the "sweet spot" of Fitbit's portfolio. Weighing in on GoPro (GPRO), the analysts wonder if the Hero5 will be compelling enough to make consumers buy another camera and note that its upcoming Karma drone is very late to market and "facing daunting odds."
08/01/16
NEED
08/01/16
NO CHANGE
Target $65
NEED
Buy
Synaptics price target lowered to $65 from $88 at Needham
Needham analyst Rajvindra Gill lowered his price target for Synaptics (SYNA) to $65 from $88 on a lower earnings multiple as he remains uncertain on whether the company has secured the OLED DDIC for Apple's (AAPL) iPhone 8 versus an internal Samsung (SSNLF) solution. The analyst reiterates a Buy rating on Synaptics' shares, saying the company will remain one of the leaders in the display markets.

TODAY'S FREE FLY STORIES

WDC

Western Digital

$90.25

-0.78 (-0.86%)

11:25
06/23/17
06/23
11:25
06/23/17
11:25
Options
Western Digital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$30.88

0.6 (1.98%)

11:22
06/23/17
06/23
11:22
06/23/17
11:22
Periodicals
VW reducing workforce at core unit more quickly than planned, Reuters says »

Volkswagen is cutting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTLA

Portola Pharmaceuticals

$38.25

-1.24 (-3.14%)

11:18
06/23/17
06/23
11:18
06/23/17
11:18
Hot Stocks
Breaking Hot Stocks news story on Portola Pharmaceuticals »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 24

    Jun

$NSD

NASDAQ Market Internals

11:17
06/23/17
06/23
11:17
06/23/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
06/23/17
06/23
11:16
06/23/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

$8.22

0.12 (1.48%)

11:10
06/23/17
06/23
11:10
06/23/17
11:10
Options
10K VALE Jan 10 calls trade at 40c on ISE »

10K VALE Jan 10 calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NURO

NeuroMetrix

$2.89

0.056 (1.98%)

11:08
06/23/17
06/23
11:08
06/23/17
11:08
Hot Stocks
NeuroMetrix provides update on Quell wearable pain relief clinical program »

NeuroMetrix provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$103.76

-0.08 (-0.08%)

11:08
06/23/17
06/23
11:08
06/23/17
11:08
Hot Stocks
As bar gets raised Deutsche Bank gets less bullish on Caterpillar »

Deutsche Bank downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$11.87

0.44 (3.85%)

11:04
06/23/17
06/23
11:04
06/23/17
11:04
Earnings
Horizon Pharma now sees FY17 net sales $985M-$1.02B, consensus $990.53M »

In May, Horizon lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$11.87

0.44 (3.85%)

11:02
06/23/17
06/23
11:02
06/23/17
11:02
Hot Stocks
Horizon Pharma completes sale of European marketing rights for Procysbi »

Horizon Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUP

PowerShares DB US Dollar Index Up

$25.14

-0.09 (-0.36%)

11:00
06/23/17
06/23
11:00
06/23/17
11:00
Options
Large spread in UPS as shares deliver gains »

Large spread in UPS as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
06/23/17
06/23
11:00
06/23/17
11:00
General news
Breaking General news story  »

St. Louis Federal Reserve…

10:55
06/23/17
06/23
10:55
06/23/17
10:55
General news
Euro$ interest rate futures are marginally lower »

Euro$ interest rate…

NVO

Novo Nordisk

$44.13

0.46 (1.05%)

10:52
06/23/17
06/23
10:52
06/23/17
10:52
Hot Stocks
Novo Nordisk reports up to 13.8% weight loss in people receiving semaglutide »

Novo Nordisk announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$110.54

1.469 (1.35%)

10:45
06/23/17
06/23
10:45
06/23/17
10:45
Options
UPS call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

WMGI

Wright Medical

$26.99

0.11 (0.41%)

10:45
06/23/17
06/23
10:45
06/23/17
10:45
Conference/Events
Wright Medical has a conference call hosted by JPMorgan »

JPMorgan Analyst Hanover…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 26

    Jun

  • 28

    Jun

  • 03

    Jul

WDC

Western Digital

$90.25

-0.78 (-0.86%)

10:40
06/23/17
06/23
10:40
06/23/17
10:40
Technical Analysis
Technical View: Western Digital trades higher as Toshiba indicates open to talks »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$12.18

1.53 (14.37%)

10:31
06/23/17
06/23
10:31
06/23/17
10:31
Hot Stocks
Synchronoss confirms receipt of Siris Capital indication of interest »

Synchronoss Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$50.81

0.175 (0.35%)

10:31
06/23/17
06/23
10:31
06/23/17
10:31
Periodicals
Target starts removing all Hampton Creek products from stores, Bloomberg reports »

Target is voluntarily…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
06/23/17
06/23
10:30
06/23/17
10:30
General news
The 2.9% May U.S. new home sales rise »

The 2.9% May U.S. new…

YY

YY

$58.32

-0.66 (-1.12%)

10:28
06/23/17
06/23
10:28
06/23/17
10:28
Conference/Events
YY management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

SYY

Sysco

$50.78

-1.9958 (-3.78%)

, USFD

US Foods

$26.33

-1.275 (-4.62%)

10:27
06/23/17
06/23
10:27
06/23/17
10:27
Hot Stocks
JPMorgan sees food distributors facing competition from Amazon »

Noting that Amazon's…

SYY

Sysco

$50.78

-1.9958 (-3.78%)

USFD

US Foods

$26.33

-1.275 (-4.62%)

PFGC

Performance Food Group

$26.00

-1.25 (-4.59%)

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

WFM

Whole Foods

$43.20

-0.06 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

ALGN

Align Technology

$149.69

0.27 (0.18%)

10:25
06/23/17
06/23
10:25
06/23/17
10:25
Conference/Events
Stifel medical technology analysts hold an analyst/industry conference call »

Research Team discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 26

    Jun

TM

Toyota

$105.10

-0.39 (-0.37%)

10:24
06/23/17
06/23
10:24
06/23/17
10:24
Conference/Events
Toyota management to meet with Needham »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

AVEO

AVEO Oncology

$0.73

0.0281 (4.02%)

10:23
06/23/17
06/23
10:23
06/23/17
10:23
Recommendations
AVEO Oncology analyst commentary  »

Piper ups AVEO Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.